Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 8Hepatitis B, Chronic 5Hepatitis B 4Fibrosis 3Lymphoma 2Virus Diseases 1Recurrence 1Paraparesis, Tropical Spastic 1Neuritis 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Liver Cirrhosis 1Leukemia-Lymphoma, Adult T-Cell 1Infections 1Hepatitis D 1HTLV-I Infections 1Esophageal and Gastric Varices 1Epstein-Barr Virus Infections 1Burkitt Lymphoma 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Tenofovir × Clear all
NCT02081469 2020-02-05

Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy

Chang Gung Memorial Hospital

Phase 4 Completed
100 enrolled

Neoplasms, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡